Cargando…

Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey

BACKGROUND: In some acute care trials, immediate informed consent is not possible, but deferred consent is often considered problematic. We investigated the opinions of patients, proxies, and physicians about deferred consent in an acute stroke trial to gain insight into its acceptability and effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Koopman, Inez, Verbaan, Dagmar, Vandertop, W. Peter, van der Graaf, Rieke, Kompanje, Erwin J. O., Post, René, Coert, Bert A., Ploem, Martine C., Sluis, Wouter M., Scheijmans, Féline E. V., Rinkel, Gabriel J. E., Vergouwen, Mervyn D. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964548/
https://www.ncbi.nlm.nih.gov/pubmed/34611811
http://dx.doi.org/10.1007/s12028-021-01357-3
_version_ 1784678245126373376
author Koopman, Inez
Verbaan, Dagmar
Vandertop, W. Peter
van der Graaf, Rieke
Kompanje, Erwin J. O.
Post, René
Coert, Bert A.
Ploem, Martine C.
Sluis, Wouter M.
Scheijmans, Féline E. V.
Rinkel, Gabriel J. E.
Vergouwen, Mervyn D. I.
author_facet Koopman, Inez
Verbaan, Dagmar
Vandertop, W. Peter
van der Graaf, Rieke
Kompanje, Erwin J. O.
Post, René
Coert, Bert A.
Ploem, Martine C.
Sluis, Wouter M.
Scheijmans, Féline E. V.
Rinkel, Gabriel J. E.
Vergouwen, Mervyn D. I.
author_sort Koopman, Inez
collection PubMed
description BACKGROUND: In some acute care trials, immediate informed consent is not possible, but deferred consent is often considered problematic. We investigated the opinions of patients, proxies, and physicians about deferred consent in an acute stroke trial to gain insight into its acceptability and effects. METHODS: Paper-based surveys were sent to patients who were randomly assigned in the Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage (ULTRA) trial between 2015 and 2018 in two tertiary referral centers and to physicians of centers who agreed or declined to participate. The primary outcome measure was the proportion of respondents who agreed with deferral of consent in the ULTRA trial. Secondary outcomes included respondents’ preferred consent procedure for the ULTRA trial, the effect of deferred consent on trust in physicians and scientific research, and the willingness to participate in future research. RESULTS: Eighty-nine of 135 (66%) patients or proxies and 20 of 30 (67%) physicians completed the survey. Of these, 82 of 89 (92%) patients or proxies and 14 of 20 (70%) physicians agreed with deferral of consent in the ULTRA trial. When asked for their preferred consent procedure for the ULTRA trial, 31 of 89 (35%) patients or proxies indicated deferred consent, 15 of 89 (17%) preferred immediate informed consent, and 32 of 89 (36%) had no preference. None of the patients’ or proxies’ trust in physicians or scientific research had decreased because of the deferred consent procedure. Willingness to participate in future studies remained the same or increased in 84 of 89 (94%) patients or proxies. CONCLUSIONS: A large majority of the surveyed patients and proxies and a somewhat smaller majority of the surveyed physicians agreed with deferred consent in the ULTRA trial. Deferred consent may enable acute care trials in an acceptable manner without decreasing trust in medicine. Future research should investigate factors facilitating the responsible use of deferred consent, such as in-depth interviews, to study the minority of participants who agreed with deferred consent but still preferred immediate informed consent. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12028-021-01357-3.
format Online
Article
Text
id pubmed-8964548
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-89645482022-04-07 Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey Koopman, Inez Verbaan, Dagmar Vandertop, W. Peter van der Graaf, Rieke Kompanje, Erwin J. O. Post, René Coert, Bert A. Ploem, Martine C. Sluis, Wouter M. Scheijmans, Féline E. V. Rinkel, Gabriel J. E. Vergouwen, Mervyn D. I. Neurocrit Care Original Work BACKGROUND: In some acute care trials, immediate informed consent is not possible, but deferred consent is often considered problematic. We investigated the opinions of patients, proxies, and physicians about deferred consent in an acute stroke trial to gain insight into its acceptability and effects. METHODS: Paper-based surveys were sent to patients who were randomly assigned in the Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage (ULTRA) trial between 2015 and 2018 in two tertiary referral centers and to physicians of centers who agreed or declined to participate. The primary outcome measure was the proportion of respondents who agreed with deferral of consent in the ULTRA trial. Secondary outcomes included respondents’ preferred consent procedure for the ULTRA trial, the effect of deferred consent on trust in physicians and scientific research, and the willingness to participate in future research. RESULTS: Eighty-nine of 135 (66%) patients or proxies and 20 of 30 (67%) physicians completed the survey. Of these, 82 of 89 (92%) patients or proxies and 14 of 20 (70%) physicians agreed with deferral of consent in the ULTRA trial. When asked for their preferred consent procedure for the ULTRA trial, 31 of 89 (35%) patients or proxies indicated deferred consent, 15 of 89 (17%) preferred immediate informed consent, and 32 of 89 (36%) had no preference. None of the patients’ or proxies’ trust in physicians or scientific research had decreased because of the deferred consent procedure. Willingness to participate in future studies remained the same or increased in 84 of 89 (94%) patients or proxies. CONCLUSIONS: A large majority of the surveyed patients and proxies and a somewhat smaller majority of the surveyed physicians agreed with deferred consent in the ULTRA trial. Deferred consent may enable acute care trials in an acceptable manner without decreasing trust in medicine. Future research should investigate factors facilitating the responsible use of deferred consent, such as in-depth interviews, to study the minority of participants who agreed with deferred consent but still preferred immediate informed consent. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12028-021-01357-3. Springer US 2021-10-05 2022 /pmc/articles/PMC8964548/ /pubmed/34611811 http://dx.doi.org/10.1007/s12028-021-01357-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Work
Koopman, Inez
Verbaan, Dagmar
Vandertop, W. Peter
van der Graaf, Rieke
Kompanje, Erwin J. O.
Post, René
Coert, Bert A.
Ploem, Martine C.
Sluis, Wouter M.
Scheijmans, Féline E. V.
Rinkel, Gabriel J. E.
Vergouwen, Mervyn D. I.
Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey
title Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey
title_full Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey
title_fullStr Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey
title_full_unstemmed Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey
title_short Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey
title_sort deferred consent in an acute stroke trial from a patient, proxy, and physician perspective: a cross-sectional survey
topic Original Work
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964548/
https://www.ncbi.nlm.nih.gov/pubmed/34611811
http://dx.doi.org/10.1007/s12028-021-01357-3
work_keys_str_mv AT koopmaninez deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey
AT verbaandagmar deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey
AT vandertopwpeter deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey
AT vandergraafrieke deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey
AT kompanjeerwinjo deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey
AT postrene deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey
AT coertberta deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey
AT ploemmartinec deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey
AT sluiswouterm deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey
AT scheijmansfelineev deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey
AT rinkelgabrielje deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey
AT vergouwenmervyndi deferredconsentinanacutestroketrialfromapatientproxyandphysicianperspectiveacrosssectionalsurvey